NRG GI005

Primary Category:

Treatment Protocols

Disease Category:

Colon, Gastrointestinal

Status:

Open

Phase II/III Study of Circulating Tumor DNA as a Predictive Biomarker in Adjuvant Chemotherapy in Patients with Stage IIA Colon Cancer (COBRA)

NCT#04068103

GI005 is reopened upon implementation of Amendment 1, effective June 15, 2021.